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In vivo exposure of experimental animals and humans 
to UV radiation, with and without the addition of pho-
tosensitizers, can alter immune responses and the func-
tion and distribution of components of the immune sys-
tem. In mice, exposure to UVB (290-320 run) radiation 
suppresses delayed hypersensitivity (DH) responses 
such as allergic contact dermatitis to simple chemicals. 
The mechanism of this effect of radiation involves an 
alteration of the function of antigen-presenting cells, 
possibly Langerhans cells, resulting in the preferential 
induction of suppressor cells; the effect is mainly exerted 
on the induction phase of the immune response. In the 
guinea pig, exposure to either UVB or methoxsalen/ 
UV A (PUV A) radiation suppresses allergic contact der-
matitis and DH to hapten-protein conjugates. There is 
suggestive evidence that UV radiation may also suppress 
cutaneous DH responses in humans. Exposure to UV 
radiation can alter the function and viability of periph-
eral blood lymphocytes in humans. Following in vitro 
exposure, these effects are both dose- and wavelength-
dependent. In vivo exposure to either UVB or PUV A 
radiation produces alterations in the function of circu-
lating lymphocytes; the significance and long-term ef-
fects of these alterations have not been explored. There 
is increasing evidence that the effects ofUVB and PUV A 
on immune function may be qualitatively different. For 
example, a single exposure of UVB radiation in humans 
produces a suppression of the response of lymphocytes 
following stimulation by phytohemagglutinin. Equi-er-
ythemogenic doses of PUV A do not have this effect. 
Furthermore, in mice exposure to UVB radiation sup-
presses the normal immune response to UVB-induced 
skin tumors. In contrast, treatment with PUV A does not 
alter this immune response. These observations may be 
important to our understanding of the mechanisms un-
derlying the beneficial and adverse effects of these 2 
radiations. 
Photoimmunology is the study of the effects of nonionizing 
radiation on normal and abnormal immune function. This area 
of research is of interest to photobiologists because it has 
revealed some striking examples of how exposure to radiation 
which is mainly absorbed in the skin can induce systemic 
changes at distant nonexposed sites. Immunologists are inter-
ested in the effects of nonionizing radiation because it is proving 
to be a useful tool for exploring the function of the immune 
system and its individual components. The subject also attracts 
the interest of dermatologists because the pathogeneses of 
certain diseases involve an interaction between nonionizing 
radiation and immune responses, the range of radiation (200-
700 nm) which affects the immune system is almost entirely 
absorbed by the skin, and the immune system is well repre-
sented in the skin. 
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Perhaps the fIrst observation in photoimmunology was that 
made by Fleischmann in 1905 [1], when he found that the 
precipitin reaction could be abolished by exposure of antisera 
to UVC (254 nm) radiation in vitro. This fInding was typical of 
many isolated observations made over the next 60 yrs, of 
interest in themselves but not forming a general picture of how 
exposure to nonionizing radiation might affect immunologic 
function. However, in the past few years this situation has 
changed due to several influences. Successful photochemo-
therapy in several diseases thought to have immunologic path-
ogeneses has focused the interest of dermatologists on the effect 
of this therapy on immune function . Immunologists have re-
cen tly shown increased interest in the effects of nonionizing 
radiation because of the observation that UV -induced altera-
tions in immune function play an important role in the patho-
genesis of UV-induced skin cancer in mice. This interest has 
now been extended to an examination of the effects of UV 
radiation on other immune responses. Instead of isolated ob-
servations, progress is being made in understanding the signif-
icance of the effects of nonionizing radiation on immunity and 
the mechanisms underlying these changes. Today it is recog-
nized that tolerable exposures of the skin of experimental 
animals and humans can diminish allergic contact dermatitis, 
diminish delayed hypersensitivity to an injected antigen, pro-
long skin-graft survival and alter the function and distribution 
of lymphocytes. 
Much of the early research in photoirnmunology has been 
recently reviewed [2,3) and therefore this discussion will focus 
on recent observations in a few selected areas. 
UV RADIATION AND DELAYED HYPERSENSITIVITY 
The effects of UV radiation on cell-dependent delayed-type 
hypersensitivity has been studied by several workers and some 
progress has been made in our understanding of the mecha-
nisms by which radiation influences this type of immune re-
sponse. 
Haniszko and Suskind in 1963 [4] observed that a mildly 
erythemogenic exposure to UVB (290-320 nm) radiation de-
creased, but did not a bolish, the response to a challenge dose of 
2,4 dinitrochlorobenzene (DNCB) in animals sensitized to that 
hapten. The effect was local at the site of exposure to radiation 
and a systemic effect was not detected. More recently it was 
found that chronic exposure of mice to UVB radiation resulted 
in a transient inability to develop delayed hypersensitivi ty to 
DNCB [5,6]. This defIciency was seen in animals exposed to 
radiat ion for up to 2 mo, but not in animals exposed for longer 
periods of time. The altered reactivity was systemic as it was 
evident at distant non exposed sites. The results of cell transfer 
experiments suggested that UV radiation produced a defect in 
antigen uptake, processing or presenta tion and that the function 
of antigen-reactive lymphoid cells from the irradiated animals 
was normal. 
Recent studies have demonstrated that exposure of mice to 
UVB radiation does result in a defect in the funct ion of antigen-
presenting cells [7]. Hapten-conjugated adherent cells from the 
spleens of UV -treated mice could not induce hapten-specifIc 
delayed hypersensitivity responses in UV-irradiated mice, 
whereas hapten-conjugated adherent cells from normal mice 
were able to do so. The failure to develop delayed hypersensi-
tivity in UV -irradiated mice was associated with the appearance 
of antigen-specifIc suppressor T lymphocytes, probably as a 
result of the altered function of antigen-presenting cells. Further 
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studies have shown that the exposure dose of UVB radiation restricted to allergic contact dermatitis. Exposure of guinea pigs 
required to interfere with the antigen-presenting function of to erythemogenic doses of UVB radiation or PUV A produced 
splenic adherent cells also suppresses the induction of allergic local and systemic suppression of the development of delayed 
contact dermatitis to a topically applied contact allergen (F. hypersensitivity following immunization with a hapten-protein 
Noonan, personal communication). Furthermore, a causal re- conjugate in complete Freund's adjuvant [18]. In this model the 
lationship between the defect of antigen presentation and sup- animals were immunized by footpad injection of the antigen 
pression of delayed hypersensitivity was supported by the find- and the challenge dose of antigen was administered by intra-
ing that both phenomena appear 3 to 5 days after exposure to dermal injection. The mechanism by willch radiation sup-
radiation. The suppression of allergic contact dermatitis as a presses this response is not known, but as with contact allergy, 
result of exposure to UVB radiation was associated with the the effect is probably exerted mainly on the induction phase of 
appearance of hapten-specific suppressor cells, probably T lym- the immune response. In another study it was found that the 
phocytes. The suppressor cells inhibited the development of survival time of full-thickness skin grafts in rabbits was pro-
contact allergy in syngeneic animals but did not affect the longed by treatment with PUVA [19]. Psoralen was adminis-
elicitation of an allergic response in animals with established tered by gavage and both the donor and recipient sites were 
sensitivity. This finding indicates that radiation probably acts exposed to erythemogenic doses of UVA radiation. The mean 
on the induction phase of the immune response. survival time in PUV A-treated animals was 13.1 days as com-
It is not known how exposure to UVB radiation might affect pared with 8.7 days in the untreated, control animals. Similar 
the function of adherent cells in the spleen. In vitro exposure of treatment of rabbits with UVB radiation did not significantly 
these cells to UVB radiation can produce a similar defect in increase the survival time of skin grafts. Again, the mechanism 
their function, as that observed after in vivo exposure [8]. underlying this effect of radiation is unknown. 
However, there is no evidence that splenic adherent cells, which Few observations have been made in humans on the effect of 
are considered to be macrophages, undergo migration through exposure to UV radiation on delayed hypersensitivity re-
the skin where they might be exposed to UVB radiation. One sponses. Exposure to UVC radiation decreased the response to 
possibility is that a photoproduct might be released from skin an intradermal injection of streptokinase/streptodurnase anti-
and affect the function of cells at distant sites, such as the gen in a single subject [20]. The effect was local and the 
spleen. Alternatively, Langerhans cells, which are members of possibility of systemic inhlbition was not explored. Treatment 
the monocyte-macrophage series, may be damaged by radiation with PUV A was suggested as the cause of an inillbition of 
and migrate to the spleen and then be recovered as splenic contact allergy to mustine hydrochloride in patients with my-
adherent cells. There is some evidence for this latter suggestion. cosis fungoides [21]. This observation was not controlled and 
Langerhans cells are altered by exposure to radiation [9,10]. In the presence of a disease known to alter immunologic respon-
a recent study [11] exposure of both men and mice to UVB siveness makes an interpretation of the study somewhat diffi-
radiation resulted in the virtual elimination of Langerhans cells cult. The percentage of positive responses following sensitiza-
from the epidermis, as judged by specific histochemical (ATP- tion and challenge with DNCB was found to be reduced in a 
ase) and functional, immunological (Ia antigens) markers. How- group of patients with psoriasis undergoing PUV A treatment 
ever, examination of the skin by electron microscopy revealed as compared with the percentage of positive responses in pa-
that the number of Langerhans cells was only reduced by 20- tients with psoriasis not being treated with PUV A [22]. A 
30% although the remaining cells were damaged. Langerhans controlled prospective study in patients being treated with 
cells do appear to be involved in antigen processing and presen- PUVA therapy will no doubt clarify this finding. Finally, a 
tation in the skin and there is some evidence that this function recent interesting observation was that higher concentrations 
may be impaired by radiation. In mice, allergic contact derma- of DNCB were required to elicit a positive response in sun-
titis to a topically applied hapten cannot be induced through damaged skin as compared to normal skin, in subjects sensitized 
skin that is deficient in Langerhans cells as a result of prior to the hapten [23). The responses to a primary irritant were 
exposure to,UVB radiation [12,13]. However, local alterations not diminished in sun-damaged skin. These findings suggest 
in Langerhans cells at the site of exposure to radiation do not that some local disturbance of delayed hypersensitivity results 
necessarily explain the systemic suppression of contact allergy from chronic sun exposure. 
observed in several animal species. Traffic of Langerhans cells Obviously, observations in humans on the effects of UV 
between the skin and internal organs or other skin sites has not radiation on delayed hypersensitivity lag far behind the elegant 
so far been observed, but it remains as a possible explanation experiments that have been conducted in animals. However, 
for the systemic effects of radiation. with the use of adequately controlled studies and appropriate 
Some of the photobiological aspects of these observations in vitro techniques it should be possible to fully explore tills 
have also attracted interest. Suppression of the induction of question. The mixed lymphocyte culture (MLC) is one in vitro 
delayed hypersensitivity to a contact allergen in mice was technique that offers promise although only the effect of in 
linearly related to the 10gIO of the dose of UVB radiation and vitro exposure to radiation has been studied. Exposure of stim-
the action spectrum involved wavelengths shorter than 320 nm, ulator cells to UVC radiation inhibits both the proliferation of 
with a peak in the 260-270 nm region [14]. However, the action lymphocytes in the responder population and the generation of 
spec:trum for an effect on allergic contact dermatitis may be cytotoxic cells (24,25]. In contrast, primed cells in a secondary 
broader than this if ph9tosensitizers are used. In guinea pigs we MLC stimulated with UVC-irradiated cells show a cytotoxic 
have found that exposure to UVB radiation and treatment with response, although the proliferative response is minimal 
methoxsalen/UV A radiation (referred to by the acronym, [26,27]. A similar dichotomy in the response of primed and 
PUV A) are both able to inhlbit the development of delayed nonprimed lymphocytes was seen when hapten-conjugated leu-
h}lJersensltivity to DNCB. This effect is seen both locally kocytes were exposed to UVC radiation prior to incubation with 
following exposure of the site of elicitation to radiation [15,16] cells from subjects sensitive to the hapten [28]. The proliferative 
and also systemically at a distant nonexposed site [17]. In response of the nonprimed responder cells was abrogated when 
animals with established contact allergy to DNCB, treatment the hapten-leukocyte conjugate was treated with UVC radia-
with PUV A for up to 14 days; using markedly erythemogenic tion; a much higher dose of radiation was required to produce 
doses, did not affect the response to a further challenge dose of the same suppression of the response in a primed, secondary 
DNCB within the site of irradiation. This observation suggests I culture. It was suggested by these workers that the antigen-
that, as has been observed in mice, radiation acts mainly during presenting cell function of the leukocytes was altered by the 
the phase of induction of the immune response. exposure to radiation and this mechanism could also be respon-
There are a few studies to indicate that suppression of de- sible for the effect of UVC radiation in the MLC. If this theory 
layed hypersensitivity by exposure to UV radiation is not is correct then primed and nonprimed lymphocytes clearly have 
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different requirements for antigen presentation. All these stud-
ies have used in vitro exposure to radiation and therefore 
cannot be readily extrapolated to the in vivo state, but they do 
point the way for future work on the effect of UV radiation on 
human immune responses. 
UV RADIATION AND LYMPHOCYTES 
The viability and function of lymphocytes are altered by 
exposure to nonionizing radiation. Following in vitro exposure 
to UV radiation a decrease in the viability of these cells occurs 
and this effect is dependent on both the dose and wavelength 
of the radiation [29,30]. UVC radiation is more toxic than UVB 
which in turn is orders of magnitude more toxic than UV A 
(320-400 nm) radiation. The toxicity of UV A radiation is greatly 
enhanced by the addition of methoxsalen [31]. The response of 
lymphocytes following stimulation by the mjtogen, phytohe-
magglutinin (PHA), is also decreased by in vitro exposure to 
UVC, UVB and UVA radiation and the relative toxicity of the 
3 wavebands is the same as observed in respect of viability 
[32]. The photosensitized reaction of UV A radiation with meth-
oxsalen also produces a dose-dependent decrease in the re-
sponse of lymphocytes to PHA [33,34]. Lymphocyte functions 
vary in their susceptibiljty to radiation. The proliferative re-
sponse to antigens (allogeneic cells and candida) was more 
sensitive to UVC radiation than cell-mediated lympholysis and 
the production of macrophage inhibitory factor [20]. 
Studies of the effects of in vitro exposure of lymphocytes to 
radiation are useful in determining the relative susceptibilities 
of different cell functions and the comparative effects of various 
wavebands. Information can be obtained of the possible direct 
effects of radiation on lymphocytes. However, such observa-
tions leave open the fundamental question of whether exposure 
to nonionizing radiation can affect lymphocytes in vivo. The 
effect of nonionizing radiation on circulating leukocytes was 
investigated by several workers in the early part of this century; 
those results have been reviewed by Laurens [35]. The sun and 
artificial sources of radiation with a variety of emission spectra 
were used in those studies. The results were often in conflict, 
but possibly indicated that acute and chronic exposure to UV 
radiation produced a lymphocytosis in the peripheral blood 
[36]. A somewhat more recent study by Spode in 1956 found 
that UVB radiation had a variable effect on the peripheral 
blood lymphocyte count in rabbits. Species differences, disease, 
acute versus chronic exposure and wavelength interactions 
when the sun was used as a radiation source, may be some of 
the factors which led to variation between the results of sepa-
rate studies. 
Interest in the effects of nonionizing radiation on lymphocytes 
in vivo has been revived with the use of PUV A therapy. This 
treatment is beneficial in mycosis fungoides and lichen planus, 
conditions in which clearance of the rash is accompanied by 
elimination of the abnormal and normal lymphocytes present 
in the cutaneous infiltrates. Therefore PUV A therapy can affect 
lymphocytes in the skin. However, it is not known whether the 
cells are killed as a result of the treatment or redistributed to 
other sites in the body. UV A radiation penetrates to the level 
of the blood and lymphatic channels in the skin and therefore 
PUV A therapy may also affect the function and viability of 
circulating lymphocytes. This possibility has been examined by 
a number of workers and although most studies have found 
some changes, the results have varied. DNA synthesis, as 
measured by in vitro tritiated thymidine incorporation, was 
diminished in some samples of unstimulated peripheral blood 
lymphocytes obtained from patients with psoriasis immediately 
following exposure to UV A radiation during a course of PUV A 
therapy [37]. Circulating T lymphocytes, as identified by the 
formation of E rosettes, were decreased after several exposures 
to PUV A therapy in patients with psoriasis [38,39] but returned 
to normal levels as treatment was continued. In normal control 
subjects, circulating T cells were decreased by exposure to 
PUV A [38] or were unaffected [39]. A diminished proportion of 
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E rosette-forming cells in the peripheral blood was also found 
in patients with a variety of diseases, all of whom were being 
treated with PUV A therapy [40]. However, other studies have 
failed to find any alteration of circulating T cells during short 
[41] or long courses [42] of PUVA therapy. In further contrast, 
the percentage ofE rosette-forming cells in the peripheral blood 
of patients with psoriasis increased during a course of PUV A 
therapy [43]. In patients with psoriasis the proportion of cir-
culating B lymphocytes, identified by the presence of surface 
membrane-immunoglobulins, was unchanged by PUVA ther-
apy in several studies [38,40,41]. The response of lymphocytes 
following stimulation with PHA has been found to be unaffected 
[42,43] or diminished [41,44] at an early stage during a course 
of therapy. These apparent conflicts between the results in 
different studies are probably due to several factors. Psoriasis 
alone affects the number of circulating E rosette-forming lym-
phocytes; the number is diminished in patients with active 
disease [39,43]. The time of blood collection relative to the last 
exposure to PUV A varied between studies or was not specified. 
Finally, PUV A therapy is not standardized and presumably the 
exposure doses administered to patients varied a great deal. 
In an attempt to overcome some of the defects of preceding 
studies and more clearly define what effect PUV A therapy 
exerts on peripheral blood lymphocytes, we gave a single whole-
body treatment of PUV A to a group of normal subjects and 
conducted serial examinations of peripheral blood lymphocytes 
[45]. Doses of radiation were selected so as to result in a marked 
erythema in some subjects and a minimal erythema in other 
subjects. Erythemogenic doses of PUV A resulted in a decrease 
in the proportion of circulating E rosette-forming cells and 
SmIg-positive lymphocytes and a corresponding increase in the 
proportion of null cells. Doses ofPUVA that resulted in minimal 
or no erythema had similar but less marked effects on lympho-
cytes. The changes appeared 30 min after exposure, were max-
imal at 12 to 16 hr and returned to pretreatment levels by 72 hr 
postirradiation. The number of circulating lymphocytes and the 
response of lymphocytes to stimulation with PHA were unaf-
fected by PUV A treatment. This study therefore demonstrated 
that exposure to nonionizing radiation, at least in the presence 
of a photosensitizer, can affect lymphocytes in vivo. The mech-
anism whereby radiation produces alterations in peripheral 
blood lymphocytes is unknown. One possibility is a direct toxic 
effect on lymphocytes as they percolate through the blood and 
lymphatic chaimels of the skin. A comparison of the in vitro 
doses of radiation required to induce alterations in lymphocytes 
and the likely dermal doses of UV A radiation in a subject 
treated with PUV A indicates that such a mechanism is quite 
possible. However, the in vivo state is complex and probably 
multiple mediators and photoproducts are liberated as a result 
of PUV A treatment. Such substances may be responsible for 
changes in the distribution and function of lymphocytes. 
The significance of the changes observed in lymphocytes 
following exposure to UV radiation is unknown. Some of the 
beneficial and harmful effects of exposure to UV radiation could 
be mediated via an effect on lymphocytes. For example, as 
mentioned above, the beneficial effect of PUV A therapy in 
mycosis fungoides is possibly due to a toxic effect of this 
treatment on the lymphoid cells of the cutaneous infiltrate. 
Disorders such as vitiligo and atopic eczema may also respond 
to PUV A therapy because of a toxic effect of PUV A on some 
lymphocyte subpopulation involved in the pathogeneses of 
these conditions. While it is interesting to speculate on the 
possible beneficial effects that might be due to a PUVA-induced 
alteration in lymphocyte function, it is perhaps of more imme-
diate concern that the possible harmful effects be considered . 
In studies reported so far all changes appear to be of short 
du.ration and reversible. However, many lymphocytes are long-
lived cells and gradual accumulation of partially-repaired le-
sions could ultimately result in defects of immune function of 
clinical importance. One obvious example of a possible harmful 
effect that could arise in this way is nonmelanoma skin cancer. 
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It is now established that renal transplant recipients treated 
with immunosuppressive agents have an increased incidence of 
skin cancer. Recently it has been reported that patients treated 
with PUV A t herapy also appear to have an increased incidence 
of nonmelanoma skin cancer. It is possible that this effect could, 
at least in part, be due to an immunosuppressive effect of 
PUVA. 
UVB RADIATION AND PUV A: SIMILAR OR 
DIFFERENT? 
Interest in photo immunology as it applies to humans has 
recently been centered mainly on the effects of PUV A therapy 
on lymphocytes. This has tended to give the impression that 
the actions of PUV A in humans are separate and distinct from 
those of radiation alone. In contrast, those workers interested 
in the effects of UV radiation on immune responses in animals 
have mainly confined therr interest to UVB radiation. It is quite 
possible that comparison studies of these 2 types of radiation in 
the same animal and in human models might increase our 
understanding of the mechanisms by which they induce alter-
ations in immune function. 
In our studies the initial impression was that, provided allow-
ance was made for differences in dosimetry, UVB radiation and 
PUV A appeared to have similar effects. Both types ofradiation 
were toxic to lymphocytes in vitro and suppressed allergic 
contact dermatitis to DNCB and delayed hypersensitivity to an 
injected antigen in animals. However, with further study differ-
ences are beginning to appear between the effects of PUV A and 
UVB radiation. 
In vitro exposure of lymphocytes to UVB radiation inhibits 
trypan blue dye exclusion by these cells at a dose that is lower 
than that required to inhibit the cellular response following 
stimulation with PHA [32]. Expressed another way, cells that 
appear to be nonviable are still capable of responding to a 
mitogen. However, following in vitro exposure to UV A radiation 
in the presence of methoxsalen, lymphocytes lose their capacity 
to exclude trypan blue at a much higher dose of radiation than 
that required to inhibit the response to PHA stimulation [3ll 
These observations suggest that the site and nature of the 
damage induced in lymphocytes by these 2 types of radiation 
al·e different. The photochemical alterations in DNA induced 
by exposure to UVB and PUV A radiation are known to be 
different and this could result in varying effects on cell function. 
Unfortunately, there is little information on the relative effects 
of these two radiations on other target molecules in cells. For 
example, one type of radiation might have a significant effect 
on cell-membrane function while the other may not, and thus 
lead to the varying effects we have observed. 
The effects of PUV A and UVB radiation on lymphocytes in 
vivo also appear to be different. As outlined above [45], a whole-
body treatment with an erythemogenic dose of PUV A in normal 
subjects resulted in a decrease in the proportion of circulating 
E rosette-forming cells and SmIg-positive cells, but the response 
of lymphocytes to PHA was not altered. A similar study was 
conducted in which normal subjects were given a whole-body 
erytqemogenic dose of UVB radiation and while this produced 
similar changes in the distribution of peripheral blood lympho-
cytes, it also inhibited" the response of these cells following 
stimulation with PHA [46]. It is possible that this was a sam-
pling effect: following exposure to PUV A, cells that would have 
given a decreased response following mitogen stimulation may 
have been removed from the circulation. However, it is also 
possible that PUV A and UVB radiation affect different popu-
lations of circulating lymphocytes. We are presently inv:estigat-
ing the latter possibility by examining the effect of both PUV A 
and UVB radiation on circulating subpopulations ofT lympho-
cytes. 
In some animal models PUV A and UVB radiation also appear 
to have different effects. As mentioned above, PUVA treatment 
was found to prolong the survival of full-thickness skin grafts in 
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rabbits. Exposure to equi-erythemogenic doses of UVB radia-
tion did not have this effect. It could be argued that erythema 
should not be used as an end-point in such a study as the actual 
dermal doses of each radiation may be different. Unfortunately, 
erythema is the only convenient end-point available. Studies of 
the immunologic responses of mice to skin tumors have also 
indicated differences between the effects of PUV A and UVB 
radiation. This work was done in collaboration with Dr. Mar-
garet Kripke. Skin tumors induced in mice by chronic exposure 
to UVB radiation are often highly antigenic and regress when 
transplanted into normal syngeneic animals, but grow progres-
sively in immunosuppressed mice. Exposure of mice to subtu-
morigenic doses of UVB radiation results in a specific systemic 
alteration rendering the animals unable to reject transplanted 
UVB-induced tumors that are rejected by normal syngeneic 
hosts. This state of heightened tumor susceptibility is accom-
panied by the appearance of suppressor T lymphocytes in the 
lymphoid tissue of mice which suppress the normal immune 
response to UVB-induced tumors. In contrast to those findings, 
we found that PUV A treatment, using either topical or systemic 
administration of methoxsalen, did not alter the susceptibility 
of mice to UVB-induced tumor transplants. Mice treated with 
both minimally and markedly photo toxic doses of PUV A re-
jected tumors with a frequency similar to that seen in control 
untreated animals. These results differ from those recently 
reported by Roberts, Schmitt, and Daynes [47], who found that 
PUV A treatment did increase susceptibility to UVB-induced 
tumors. However, there were differences between their study 
and ours and perhaps the most important of these was the 
emission spectra of the radiation sources. The UV A radiation 
source used by Roberts, Schmitt, and Daynes emitted a signifi-
cant amount of UVB radiation which could have been respon-
sible for the altered tumor susceptibility. In our study a mylar 
fllter was used to eliminate wavelengths shorter than 320 nm so 
as to confine the effects to those produced by the interaction of 
methoxsalen/UV A radiation. A further observation made in 
our study was that PUV A-induced tumors grew equally well in 
normal and UVB-treated mice. In summary, PUVA and UVB 
radiation appear to induce different immunological changes in 
mice and the immunologic features of tumors induced by these 
2 radiations are also different. 
An appreciation and greater understanding of the differences 
between the immunologic effects of PUV A and UVB radiation 
may help explain differences between the therapeutic effects of 
these two types of radiation. PUV A therapy is beneficial in 
vitiligo, mycosis fungoides and atopic eczema, conditions that 
have not been shown to respond to UVB phototherapy. Lymph-
oid cells and abnormal immunologic responses are thought to 
be involved in the pathogeneses of these conditions and the 
differing responses to the treatments may reflect different ef-
fects of PUV A and UVB radiation on immunologic function. 
PUV A therapy and UVB phototherapy appear to be almost 
equally effective in clearing skin disease in patients with pso-
riasis. However, these 2 treatments are not equally effective for 
maintaining a disease-free state. PUV A therapy can often main-
tain a disease-free state in patients with psoriasis by 1 or 2 
exposures each month, whereas effective maintenance with 
UVB phototherapy may require as much as one or two treat-
ments each week (J.A. Parrish, personal communication). One 
theory to explain the different effects of these treatments in 
psoriasis is that both PUV A and UVB radiation clear disease 
by inhibition of DNA synthesis and cell proliferation, that UVB 
therapy maUltains a clear state by the same mechanism, but 
that PUVA maintenance therapy acts by suppressing an ab-
normal immunologic response that triggers the disease. 
It is perhaps not surprising that PUV A and UVB radiation 
, have different effects on immune function because there are 
other situations where the responses to these treatments vary. 
Photochemical alterations in DNA, DNA-repair pathways, 
depth of penetration through the skin, duration and timing of 
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visible and histologic changes in the skin and the extent of 
vessel damage, are all examples in which UVB and PUV A 
treatment have different effects. Some of these differing effects 
may be responsible for the variation in the actions of the 2 
treatments on immunologic function. 
POTENTIALS IN PHOTOIMMUNOLOGY 
The past few years have been marked by considerable ad-
vances in the understanding of the effects of UV radiation on 
immune responses in animals. However, as in many other areas 
of immunology, progress in human studies has been much 
slower. This should be corrected and the results of the animal 
studies can be used as a guide to which areas of study al·e likely 
to be most productive in humans. The effect of radiation on 
delayed hypersensitivity and the immunobiology of photocar-
cinogenesis in humans stand out as 2 worthwhile areas of 
research. The practical applications of such research are not 
immediately evident but the possibilities include deliberate 
manipulation of immune responses for therapeutic benefit and 
a greater understanding of the pathogenesis of skin cancer. 
Finally, an area of photoimmunology which did attract a lot of 
interest from dermatologists, namely the photosensitivity dis-
eases that may have an immune pathogenesis, have been largely 
neglected during the past decade. Photoallergy and solar urti-
caria, among others, require study with modern immunologic 
techniques. 
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Announcement 
The American Board of Dermatology and The American Board of Pathology: Examination for Special 
Competence in Dermatopathology. Notice to Diplomates who wish to apply under the "experience" 
category. 
The final expiration date for applications under the "experience" category is December 31, 1981. The 
Dermatopathology Qualifications Committee will consider applications from persons who hold a basic 
certificate from the American Board of Dermatology or the American Board of Pathology (anatomic 
pathology, or anatomic and ·clinical pathology) and 2 yr of experience in dermatopathology acceptable to 
the Committee. The training requirements for basic certification must have been completed before 
December 31, 1977, and the 2 yr of acceptable experience in dermatopathology must have been completed 
before December 31, 1979. . 
After December 31, 1981, applications will be accepted ONLY from those candidates (regardless of the 
date of completion of residency training) who have had 1 yr of full-time residency training in Dermato-
pathology in a Dermatopathology residency training program which has been approved by the Residency 
Review Committee for Dermatopathology and accredited by the Liaison Committee for Graduate Medical 
Education. 
Persons who believe they may qualify for the special competence examination in Dermatopathology as 
a result of the "experience" clause should request an application form from the office of either the 
American Board of Dermatology or the American Board of Pathology. 
